Flow cytometry revealed a significant increase in the percentage of CD4+ T-cells expressing integrin β7 (p = 0.023 vs. IBS; Fig. 1A), and CD62L (p = 0.026; Fig. 1B) in IBS patients when compared to HV. Here, SELL is linked to irritable bowel syndrome.